Search research articles
Contact Us
Filters
Showing results (21-30 of 105) with videos related to
Page
of 11
Sort By:
Anti-Cancer Drugs
|
December 8, 2020
Panniculitis in a patient with metastatic renal cell carcinoma on a tyrosine kinase inhibitor
Nellie N Nafissi, Nina Karlin, Mark R Pittelkow, et al.
JAAD International
|
August 19, 2021
The policy dimensions, regulatory landscape, and market characteristics of teledermatology in the United States
Pranav Puri, James A Yiannias, Aaron R Mangold, et al.
World Journal of Emergency Medicine
|
September 13, 2014
Flashback phenomenon and residual neurological deficits after the use of "bath salt" 3, 4- methylenedioxypyrovalerone
Aaron R Mangold, Thomas P Bravo, Stephen J Traub, et al.
International Orthopaedics
|
July 28, 2019
Reverse shoulder arthroplasty for rheumatoid arthritis since the introduction of disease-modifying drugs
Devin R Mangold, Eric R Wagner, Robert H Cofield, et al.
International Journal of Dermatology
|
September 29, 2023
Treatment options for necrobiosis lipoidica: a systematic review
Aman Nihal, Avrom S Caplan, Misha Rosenbach, et al.
International Journal of Women'S Dermatology
|
May 19, 2025
Concordance of DLQI and pain score in hidradenitis suppurativa clinical trials: a systematic review
Adina Greene, Angelina S Hwang, Sarah Amjad, et al.
Journal of Cutaneous Pathology
|
February 7, 2018
Melanoma mimicking Rosai-Dorfman disease
Daniel Y Xie, Collin M Costello, Helen J Liang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 28, 2020
Treatment of granuloma annulare and related granulomatous diseases with sulphasalazine: a series of 16 cases
Y W Yang, M D Lehrer, A R Mangold, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 28, 2017
Educational and practice gaps in the management of volar melanocytic lesions
C M Costello, S Ghanavatian, M Temkit, et al.
Cancer Medicine
|
January 8, 2024
Factors influencing receipt and time to treatment of immunotherapy relative to chemotherapy in stage III and stage IV melanoma
Gurman S Dhaliwal, Ahmad B Shahin, Elisabeth S Lim, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 105) with videos related to
Sort By:
Page
of 11
Anti-Cancer Drugs
|
December 8, 2020
Panniculitis in a patient with metastatic renal cell carcinoma on a tyrosine kinase inhibitor
Nellie N Nafissi, Nina Karlin, Mark R Pittelkow, et al.
JAAD International
|
August 19, 2021
The policy dimensions, regulatory landscape, and market characteristics of teledermatology in the United States
Pranav Puri, James A Yiannias, Aaron R Mangold, et al.
World Journal of Emergency Medicine
|
September 13, 2014
Flashback phenomenon and residual neurological deficits after the use of "bath salt" 3, 4- methylenedioxypyrovalerone
Aaron R Mangold, Thomas P Bravo, Stephen J Traub, et al.
International Orthopaedics
|
July 28, 2019
Reverse shoulder arthroplasty for rheumatoid arthritis since the introduction of disease-modifying drugs
Devin R Mangold, Eric R Wagner, Robert H Cofield, et al.
International Journal of Dermatology
|
September 29, 2023
Treatment options for necrobiosis lipoidica: a systematic review
Aman Nihal, Avrom S Caplan, Misha Rosenbach, et al.
International Journal of Women'S Dermatology
|
May 19, 2025
Concordance of DLQI and pain score in hidradenitis suppurativa clinical trials: a systematic review
Adina Greene, Angelina S Hwang, Sarah Amjad, et al.
Journal of Cutaneous Pathology
|
February 7, 2018
Melanoma mimicking Rosai-Dorfman disease
Daniel Y Xie, Collin M Costello, Helen J Liang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 28, 2020
Treatment of granuloma annulare and related granulomatous diseases with sulphasalazine: a series of 16 cases
Y W Yang, M D Lehrer, A R Mangold, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 28, 2017
Educational and practice gaps in the management of volar melanocytic lesions
C M Costello, S Ghanavatian, M Temkit, et al.
Cancer Medicine
|
January 8, 2024
Factors influencing receipt and time to treatment of immunotherapy relative to chemotherapy in stage III and stage IV melanoma
Gurman S Dhaliwal, Ahmad B Shahin, Elisabeth S Lim, et al.
Page
of 11